Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Laraki, N. Articles by Galleni, M. Search for Related Content PubMed PubMed Citation Articles by Laraki, N. Articles by Galleni, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 1999, p. 902-906, Vol. 43, No. 4
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Biochemical Characterization of the Pseudomonas aeruginosa 101/1477 Metallo--Lactamase IMP-1 Produced by Escherichia coli

Nezha Laraki,¹ Nicola Franceschini,² Gian Maria Rossolini,³ Pasqualino Santucci,² Cécile Meunier,⁴ Edwin de Pauw,⁴ Gianfranco Amicosante,² Jean Marie Frère,¹ and Moreno Galleni^1,*

Laboratoire d'Enzymologie & Centre d'Ingénierie des Protéines, Institut de Chimie,¹ and Département de Chimie Générale & Chimie Physique, B6 Sart Tilman,⁴ Université de Liège, B-4000 Liège, Belgium, and Dipartimento di Scienze & Tecnologie Biomediche, Università dell'Aquila, I-67100 Loc Coppito, L'Aquila,² and Dipartimento di Biologia Molecolare, Sezione di Microbiologia, Università di Siena, I-53100 Siena,³ Italy

Received 1 June 1998/Returned for modification 5 October 1998/Accepted 5 January 1999

	ABSTRACT

Top Abstract Introduction Materials and Methods References

The bla_IMP gene coding for the IMP-1 metallo--lactamase produced by a Pseudomonas aeruginosa clinical isolate (isolate 101/1477) was overexpressed via a T7 expression system in Escherichia coli BL21(DE3), and its product was purified to homogeneity with a final yield of 35 mg/liter of culture. The structural and functional properties of the enzyme purified from E. coli were identical to those of the enzyme produced by P. aeruginosa. The IMP-1 metallo--lactamase exhibits a broad-spectrum activity profile that includes activity against penicillins, cephalosporins, cephamycins, oxacephamycins, and carbapenems. Only monobactams escape its action. The enzyme activity was inhibited by metal chelators, of which 1,10-o-phenanthroline and dipicolinic acid were the most efficient. Two zinc-binding sites were found. The zinc content of the P. aeruginosa 101/1477 metallo--lactamase was not pH dependent.

	INTRODUCTION

Top Abstract Introduction Materials and Methods References

The ingenuity of chemists has produced a large number of new potent antimicrobial agents, but resistant bacterial strains have consistently emerged. The case of the -lactam compounds is a good example. Bacteria have developed several strategies to escape the activities of these lethal molecules: synthesis of -lactamases, enzymes which hydrolyze the -lactam antibiotics, decreased target sensitivity, the development of efflux systems, and/or modification of the diffusion barrier (14). The production of -lactamase is the most prevalent mechanism of resistance to -lactams. To date, more than 200 different -lactamases have been described and characterized (3). Their catalytic mechanisms involve either an active-site serine residue (serine -lactamase) or a divalent transition metal ion (metallo--lactamase) (27).

Metallo--lactamases are endogenously produced by some gram-positive and gram-negative species including Bacillus cereus (17), a cluster of Bacteroides fragilis (9), Stenotrophomonas maltophilia (25, 28), some Aeromonas spp. (20), and Chryseobacterium meningosepticum (24). Recently, a metallo--lactamase (IMP-1), encoded by a mobile gene (bla_IMP) located on an integron-like element, was found in some clinical isolates of Serratia marcescens, Klebsiella pneumoniae, Pseudomonas aeruginosa, Pseudomonas putida, and Alcaligenes xylosoxidans that acquired the gene by horizontal transfer (18, 19, 29, 30). From the clinical point of view and due to the ability of the bla_IMP gene to rapidly spread among such major pathogens, the IMP-1 enzyme currently represents the most dangerous metallo--lactamase.

Metallo--lactamases constitute a heterogeneous family. Although their primary structures exhibit a relatively low degree of sequence isology (23) (most often less than 40% and sometimes less than 11% identical residues), their three-dimensional structures show a high degree of similarity (4-6) and they share four main characteristics: (i) inactivation of the carbapenem antibiotics, (ii) no interaction with monobactams, (iii) susceptibility to chelating agents such as EDTA and dipicolinic acid, and (iv) the presence of Zn²⁺ ions as the naturally occurring cations, although the Cd²⁺ and Co²⁺ derivatives are enzymatically active in vitro (27). Two zinc-binding sites are present in the molecule (4, 6, 8). The three-dimensional structure of the B. cereus 569H metallo--lactamase shows that the side chains of residues His86, His88, and His149 and a water molecule provide the metal ligands in the first binding site. The second involves the side chains of residues Asp90, Cys168, and His210 (4, 6). By one possible catalytic mechanism, the zinc ion acts as a Lewis acid to stabilize the transient tetrahedral intermediate formed by the nucleophilic attack of a hydroxide ion on the carbonyl group of the -lactam ring. The hydroxide ion is provided by the water molecule present in the active site which interacts with Asp90. This residue might act as a general base by subtracting a proton from the water molecule (2).

Metallo--lactamases are not sensitive to the conventional -lactamase inhibitors of their active-site serine counterparts and, except for the enzymes produced by Aeromonas species, exhibit a broad-spectrum activity profile against -lactams (11, 12, 13). This also appears to be the case for the IMP-1 enzyme, according to a previous study performed with a limited number of substrates (21, 22). However, a detailed analysis of the IMP-1 properties has not yet been performed.

In this study, the enzymatic activity of the IMP-1 metallo--lactamase was determined on a large number of substrates. A system for the overproduction of the enzyme in Escherichia coli and a simplified purification protocol were developed. The properties of the recombinant IMP-1 enzyme produced in E. coli were shown to be identical to those of the original enzyme produced by the P. aeruginosa clinical isolate. The effects of various chelating agents on the enzyme activity and the pH dependence of the zinc content were also measured.

	MATERIALS AND METHODS

Top Abstract Introduction Materials and Methods References

Bacterial strains and culture conditions. P. aeruginosa 101/1477 (a clinical isolate from Japan producing IMP-1) was a gift of D. Livermore (Antibiotic Reference Unit, Central Public Health Laboratory, London, United Kingdom). E. coli DH5 [supE4 lacU169 (80lacZM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1] was used as the host for recombinant plasmids, and E. coli BL21(DE3) [hsdS gal(cIts857 ind1 Sam7 nin5 lacUV5-T7 gene 1)] was used for the overexpression of the IMP-1 enzyme via the T7 expression system (Novagen Inc., Madison, Wis.). The bacteria were grown aerobically at 37°C in Luria-Bertani medium supplemented, when necessary, with the appropriate antibiotics (kanamycin at 50 µg/ml or ampicillin at 100 µg/ml) for plasmid selection. Plasmid PCR II (Invitrogen BV, NV Leek, The Netherlands) was used as the vector for the cloning and sequencing of a PCR-amplified fragment of the bla_IMP gene. Plasmid pET9a (Novagen Inc.) was used as a T7-based expression vector for the overexpression of the bla_IMP gene in E. coli.

Antibiotics and other chemicals. Benzylpenicillin, ampicillin, cephalothin, and cephaloridine were purchased from Sigma Chemical Co. (St. Louis, Mo.). Nitrocefin was purchased from Unipath (Milan, Italy). Cefoxitin and imipenem were gifts of Merck Sharp & Dohme Research Laboratories (Rahway, N.J.). Piperacillin was a gift of Lederle Wyeth (Catania, Italy). Cefpirome, cefotaxime, and desacetyl-cefotaxime were gifts of Hoechst AG (Frankfurt, Germany). Aztreonam was a gift of the Squibb Institute for Medical Research (Princeton, N.J.). Cefuroxime and ceftazidime were gifts of Glaxo Wellcome (Verona, Italy). Carumonam was a gift of Hoffmann-La Roche (Basel, Switzerland). Temocillin, carbenicillin, and ticarcillin were gifts of SmithKline Beecham Pharmaceuticals (Brentford, United Kingdom). Moxalactam and loracarbef were gifts of Ely Lilly & Co. (Indianapolis, Ind.). Cefepime was a gift of Bristol Meyers (Wallingford, Conn.). Meropenem was a gift of Zeneca Pharmaceuticals (Cheshire, United Kingdom). Biapenem was a gift of Cyanamid (Catania, Italy). Panipenem was a gift of Sankyo Co. Ltd., Biological Research Laboratories (Tokyo, Japan). EDTA, EGTA, pyridine-2,6-dicarboxylic acid (dipicolinic acid), and 1,10-o-phenanthroline were purchased from Sigma, kanamycin was purchased from Merck (Darmstad, Germany), and isopropyl--D-thiogalactopyranoside (IPTG) was purchased from Eurogentech (Liège, Belgium).

Recombinant DNA methodology. Plasmid pBCAM-52R, a pBCSK vector containing a cloned copy of the bla_IMP gene of P. aeruginosa 101/1477 (19), was used as a source of the gene for PCR amplification of the moiety of the bla_IMP gene corresponding to the NH₂-terminal sequence of the protein. A new restriction site (NdeI) was introduced directly before the bla_IMP gene by PCR. The oligonucleotide primers used for the PCR were imp-NdeI (5'-CATATGAGCAAGTTATCTGTATTCTTTATA-3') and imp-SmaI (5'-AGTGTGTCCCGGGCCTGG-3') (the underscores indicate the NdeI and SmaI restriction sites, respectively).

The PCR was performed with 25 ng of pBCAM-52R and 5 U of Taq DNA polymerase, which were incubated in the reaction buffer proposed by the Taq manufacturer. After 4 min at 95°C, 30 cycles of amplification were performed under the following conditions: denaturation for 30 s at 95°C, annealing for 1 min at 58°C, and extension for 1 min at 72°C. The PCR product was cloned into plasmid PCR II to yield pCIP2 and was sequenced by the Sanger method with a fluorescent universal primer on an ALF DNA sequencer (Pharmacia, Uppsala, Sweden) (1). A SmaI-BamHI fragment was isolated from pBCAM-52R and was subcloned into pCIP2 to yield pCIP3. The NdeI-BamHI fragment of pCIP3 containing the entire bla_IMP open reading frame was subcloned into pET 9a, which had been digested with the same enzymes, to obtain pCIP4, and pCIP4 was transformed into E. coli BL21(DE3).

Expression and purification of the IMP-1 -lactamase. The zinc -lactamase was produced by E. coli BL21(DE3) carrying pCIP4 in Luria-Bertani medium at 37°C under orbital agitation. Kanamycin (50 µg/ml) was used as the selecting agent during the growth of the bacteria. At an A₆₀₀ of 0.6, IPTG (final concentration, 1 mM) was added, and the culture was further incubated for 2 h and centrifuged at 5,000 × g for 10 min. The pellet was resuspended in 50 mM HEPES (pH 7.5) containing 50 µM ZnSO₄ (buffer H), and the cells were disrupted with the help of cell disrupter equipment (Basic Z Model; Constant Systems Ltd., Warwick, United Kingdom). The lysate was clarified by centrifugation at 30,000 × g for 20 min in order to eliminate the cell debris. The solution was loaded onto an S-Sepharose FF column (2 by 30 cm; Pharmacia) equilibrated in 50 mM HEPES (pH 7.5)-50 µM ZnSO₄ (buffer H). The column was washed with the same buffer, and the enzyme was eluted with the help of a linear NaCl gradient (0 to 0.5 M). The active fractions were pooled and concentrated by ultrafiltration with a YM-10 membrane (Amicon, Beverly, Mass.). The protein solution was dialyzed against buffer H and was loaded onto a MonoS column (0.5 by 5 cm; Pharmacia) that had been prequilibrated in buffer H. The enzyme was eluted with the help of a linear salt gradient (0 to 0.5 M). The active fractions were collected, pooled, and concentrated to 1 mg/ml by ultrafiltration as described above. The enzymatic solution was stored at 70°C.

Purification of the IMP-1 enzyme from P. aeruginosa 101/1477 was done as described by Watanabe et al. (29).

Protein analysis techniques. The N-terminal sequence was determined with the help of a gas-phase sequencer (Prosite; 492 protein sequencer; Applied Biosystems, Foster City, Calif.). The M_r value of the enzyme was determined on an electrospray mass spectrometer (VG Platform; Micromass, Fisons, United Kingdom) in acetonitrile-water (50:50 [vol/vol]; pH 6.5). The source temperature was kept at 80°C. The sample was directly introduced into the ionization chamber (at atmospheric pressure) through a steel capillary at a flow rate of 40 µl/min. The sampling cone voltage was maintained at 40 V.

Kinetic parameters. The hydrolysis of the antibiotics by the IMP-1 metallo--lactamase was monitored by monitoring the variation in absorbance resulting from the opening of the -lactam ring under the experimental conditions reported in Table 1. All the measurements were made on an Uvikon 80 spectrophotometer connected to a personal computer via an RS232C interface. All the reactions were performed in a total volume of 500 µl. All the solutions were made in 50 mM HEPES (pH 7.5)-50 µM ZnSO₄. Bovine serum albumin (final concentration, 20 µg/ml) was added to the diluted solutions of -lactamase to prevent enzyme denaturation. The steady-state kinetic parameters (K_m and k_cat) were determined by analyzing the complete hydrolysis time courses as described by De Meester et al. (10). When the K_m value was too small (K_m  20 µM), it was measured as a K_i in a competition experiment with 100 µM nitrocefin as the reporter substrate (15). The initial rate of hydrolysis of the reporter substrate was measured in the presence of different concentrations of the compounds that were studied. The k_cat values were then obtained by monitoring the hydrolysis of the antibiotic at a concentration 10 times the K_m.

View this table: [in this window] [in a new window]   TABLE 1.   Experimental conditions for kinetic studies

Inactivation of the metallo--lactamase by chelating agents. The loss of -lactamase activity was monitored in the presence of EDTA, EGTA, dipicolinic acid, and 1,10-o-phenanthroline. The progressive inactivation of the enzyme (2.5 nM) by EDTA, EGTA, 1,10-o-phenanthroline, and dipicolinic acid was monitored in the presence of 100 µM nitrocefin (reporter substrate) in a total volume of 500 µl. All the solutions were prepared in 50 mM HEPES (pH 7.5). The rate constants characterizing the inactivation of the enzyme were derived from the dependence of the pseudo-first-order constant k_i upon the chelating agent concentration, on the basis of scheme 1, in which E.Zn, C, E.Zn.C, E, and Zn.C are the metalloenzyme, the chelator, a ternary metalloenzyme-chelator complex, the apoenzyme, and the metal-chelator complex, respectively, as follows: K represents the dissociation constant of the E.Zn.C ternary complex, k₊₂ is the individual rate constant for the dissociation of E.Zn.C, and k₂ is the second-order rate constant for the formation of the ternary complex. Because [Zn.C] was higher than [E], the formation of the ternary complex from the apoenzyme and the Zn-chelator complex was characterized by the pseudo-first-order rate constant k'₂ = k₂ [C]. The values of the individual rate constants were obtained with the help of the following equation, in which K_m,S and [S] are the K_m of the reporter substrate and the concentration of the reporter substrate, respectively:

(1)

When the K value is much larger than the chelator concentration, this equation simplifies to the following:

(2)

Determination of the metal pH dependence of the metal content of the IMP-1 metallo--lactamase. Inductively coupled plasma mass spectrometry (ICPMS) was used to determine the pH dependence of the metal content of the metallo--lactamase. All the determinations were done after an overnight dialysis at 4°C against 300 volumes of buffer. The enzyme concentration was 38 µM. The following buffers were used: citric acid-sodium citrate (pH 5), acetic acid-sodium acetate (pH 5), sodium cacodylate-HCl (pH 6, 6.5, and 7), and HEPES-HCl (pH 7.5 and 8). The concentration of the buffering component was 50 mM in all cases. The catalytic efficiencies of the various dialyzed enzyme solutions were determined against imipenem.

	RESULTS AND DISCUSSION

Overexpression and purification of the IMP-1 -lactamase. The protocol originally used for the purification of the IMP-1 metallo--lactamase involved an ammonium sulfate precipitation step followed by two column chromatographies (23, 29). In our hands, with P. aeruginosa 101/1477 as the enzyme source, the yield of the procedure was low (<40%). In order to facilitate the study of the enzyme, the bla_IMP gene was cloned into a T7 expression vector (pET9a) and was overexpressed in E. coli BL21(DE3). In this strain, under the conditions described in the Materials and Methods section, high levels of enzyme accumulated in the periplasmic space. As a consequence, the purification protocol was simplified and avoided the ammonium sulfate precipitation step. Moreover, the purification yield was increased to >93%, as reported in Table 2. By using this system and the simplified purification protocol the average yield of pure enzyme was 35 mg per liter of culture. The specific activity of the purified enzyme toward nitrocefin was 19.5 µmol s¹ mg¹. The pI value was 9 ± 0.2, which was not significantly different from that observed with the enzyme purified from the original P. aeruginosa strain.

View this table: [in this window] [in a new window]   TABLE 2.   Summary of purification of metal-dependent -lactamase of P. aeruginosa 101/1477 produced in E. coli BL21(DE3)a

The N-terminal sequence of the IMP-1 -lactamase produced by E. coli was NH₂-AESLP, showing that the processing of the proenzyme was identical in E. coli and P. aeruginosa 101/1477 (19). Moreover, the N-terminal sequence was identical to that reported by Muramo et al. (21) and Osano et al. (22). These data suggested that the enzymes produced by different S. marcescens strains and P. aeruginosa were closely related.

Mass spectrometry confirmed the homogeneity of the preparation (data not shown). The measured M_r was estimated to be 25,103 ± 10, which is in good agreement with that deduced from the amino acid sequence (M_r, 25,111).

Kinetic parameters of the IMP-1 enzyme. The values of k_cat and K_m for a representative set of antibiotics are presented in Table 3. The enzyme exhibited a broad-spectrum activity profile but did not significantly hydrolyze the monobactam compounds aztreonam and carumonam (k_cat/K_m < 0.0001 µM¹ s¹). A high concentration (1 mM) of the various monobactams did not affect the rate of hydrolysis of 100 µM nitrocefin. A prolonged incubation (3 h) of the enzyme in the presence of 1 mM monobactams did not modify its activity.

View this table: [in this window] [in a new window]   TABLE 3.   Kinetic parameters of the P. aeruginosa metallo--lactamase at pH 7 and 30°C

For penicillins, the structure of the C-6 side chain played an important function. Ampicillin behaved as a good substrate (k_cat/K_m = 5 µM¹ s¹). Substitution of the amino group by a bulky group (for piperacillin, k_cat/K_m = 0.72 µM¹ s¹) or a carboxylic function (for carbenicillin, k_cat/K_m = 0.02 µM¹ s¹) decreased the catalytic efficiency. For carbenicillin, the large K_m value did not allow the determination of the individual kinetic parameters. Temocillin was neither recognized nor hydrolyzed by the IMP-1 -lactamase, as observed for the Zn -lactamase produced by B. cereus 569H (11), while ticarcillin was poorly hydrolyzed (k_cat/K_m = 0.0015 µM¹ s¹). This difference may be explained by the presence of an -methoxy group at position C-6 of temocillin. A 3-h incubation of the enzyme in a 2 mM solution of temocillin did not affect the activity of IMP-1.

All the cephalosporin derivatives tested were well recognized and hydrolyzed by the IMP-1 enzyme. The catalytic efficiency varied from 0.2 to 3 µM¹ s¹. Except for the K_m and k_cat values for desacetyl-cefotaxime, the values of K_m and k_cat were small compared to those for the best penicillins. Interestingly, the modification of the C-3 side chain affected the K_m value, which was larger for desacetyl-cefotaxime than for cefotaxime. The comparison of the kinetic constant for the hydrolysis of cephalothin and cefoxitin indicated that the presence of an -methoxy group at position C-7 did not affect the activity of the metallo--lactamase. Both compounds are good substrates for IMP-1, and their kinetic parameters are similar. Moxalactam (an oxacephem compound) is also a good substrate. Oximinocephalosporins (cefotaxime, ceftazidime) were efficiently recognized and relatively well hydrolyzed by the -lactamase, with catalytic efficiencies of >0.1 µM¹ s¹. Loracarbef was well hydrolyzed (k_cat/K_m = 0.9 µM¹ s¹).

All the carbapenem compounds tested (imipenem, biapenem, meropenem, and panipenem) behaved as good substrates (k_cat/K_m = 0.12 to 6 µM¹ s¹).

The kinetic parameters of the enzymes produced by P. aeruginosa 101/1477 and E. coli BL21(DE3) against a panel of selected substrates were quite similar in our laboratory. For the enzyme purified from P. aeruginosa 101/1477, the indicated k_cat, K_m, and k_cat/K_m values were found for benzylpenicillin (k_cat = 280 ± 50 s¹, K_m = 600 ± 30 µM, k_cat/K_m = 0.47 µM¹ s¹), cefuroxime (k_cat = 10 ± 2 s¹, K_m = 45 ± 9 µM, k_cat/K_m = 0.22 µM¹ s¹), ceftazidime (k_cat = 8 ± 2 s¹, K_m = 35 ± 5 µM, k_cat/K_m = 0.22 µM¹ s¹), cefotaxime (k_cat = 2 ± 0.5 s¹, K_m = 4 ± 0.5 µM, k_cat/K_m = 0.5 µM¹ s¹), cephaloridine (k_cat = 50 ± 10 s¹, K_m = 20 ± 10 µM, k_cat/K_m = 2.5 µM¹ s¹), and imipenem (k_cat = 40 ± 4 s¹, K_m = 40 ± 5 µM, k_cat/K_m = 1 µM¹ s¹).

Our kinetic data are in good agreement with the data reported by Muramo et al. (21), confirming that our enzyme was similar to the carbapenemase from S. marcescens FHSM4055. Surprisingly, we found major discrepancies with the kinetic data obtained by Osano et al. (22) with the metallo--lactamase of S. marcescens TN9106. The differences observed for the K_m values might be due to different assay conditions.

The catalytic properties of IMP-1 toward -lactam antibiotics were similar to those exhibited by two other clinically relevant metallo--lactamases, those of B. fragilis CcrA (31) and S. maltophilia (7, 11, 12, 13). IMP-1 is the most active against moxalactam and cefoxitin. These compounds are poorly hydrolyzed by the B. cereus enzyme and are poor inactivators of the Aeromonas -lactamase. Among all the studied Zn -lactamases, the Aeromonas enzyme (CphA) can be considered a strict carbapenemase since it is significantly active only against carbapenems. Cephaloridine and cefoxitin are poorly hydrolyzed or behave as inactivators, respectively. All the other known metalloenzymes exhibit broad spectra of activity. For example, the oximinocephalosporins cefotaxime and ceftazidime are well hydrolyzed by these enzymes. By contrast, none of the Zn -lactamases could hydrolyze monobactams such as aztreonam.

Influence of the zinc ion concentration on the enzyme activity. At pH 7.5, when increasing Zn²⁺ ion concentrations were added to the enzyme, the initial rate of nitrocefin hydrolysis was not affected. The k_cat and K_m values in the absence (K_m = 63 ± 10 µM, k_cat = 27 ± 3 s¹, k_cat/K_m = 0.4 µM¹ s¹) and in the presence (K_m = 60 ± 15 µM, k_cat = 30 ± 5 s¹, k_cat/K_m = 0.5 µM¹ s¹) of 100 µM Zn²⁺ were not significantly different.

Inactivation by Zn-chelating agents. Of the four chelating agents tested, EDTA and EGTA behaved as poor inactivators (Table 4). Even at final concentrations of 10 mM and after 1 h, the activity was reduced by only 10%. For 1,10-o-phenanthroline and dipicolinic acid, a time-dependent pseudo-first-order inactivation was observed. The value of the pseudo-first-order rate constant k_i increased with the concentration of the chelating agent in a hyperbolic manner with dipicolinic acid and linearly with 1,10-o-phenanthroline. These data indicate that the chelators do not act by scavenging the free metal but act via the formation of a transient enzyme-metal-chelator ternary complex. In the case of dipicolinic acid, the curve was analyzed on the basis of equation 1 assuming that k₂' was negligible. With 1,10-o-phenanthroline, on the basis of equation 2, k₂' was obtained by extrapolation of the line to the ordinate.

View this table: [in this window] [in a new window]   TABLE 4.   Individual parameters for inactivation of P. aeruginosa 101/1477 metallo--lactamase by chelating agents

1,10-o-Phenanthroline and dipicolinic acid inactivated IMP-1 with a rather good efficiency (k₊₂/K > 100 µM¹ s¹). The Zn enzyme produced by A. hydrophila was more efficiently inhibited by the chelating agents than IMP-1 (16). For example, the K values for dipicolinic acid were 5 and 300 µM for CphA and IMP-1, respectively.

pH dependence of activity and zinc content of IMP-1. The pH dependence of the Zn content of the metallo--lactamase of P. aeruginosa was measured by ICPMS (Table 5). Cd(II), Co(II), Ca(II), Cu(II), Mn(II), and Ni(II) were not found. In the absence of excess of metal and between pH 6 and pH 8, the enzyme contained almost two zinc ions per molecule. At pH 5 the nature of the buffer influenced the [Zn]/[enzyme] molar ratio. In citrate buffer, the ratio decreased to a value of 0.3, while in acetate buffer, the ratio was close to 2. Finally, the pH dependence of the catalytic efficiency of the enzyme against imipenem in the absence of added Zn²⁺ was determined. The IMP-1 metallo--lactamase exhibited a maximum activity against imipenem between pH 6.5 and pH 7.5. All metallo--lactamases studied exhibit two Zn-binding sites. However, the occupancy of the second binding site has a different effect on the catalytic activities of the enzymes. For the B. cereus 569H enzyme, the catalytic efficiency is not strongly modified by the presence of a second zinc ion (2). The A. hydrophila AE036 enzyme is fully active with one zinc, but its activity is inhibited by the binding of a second zinc ion (16). The B. fragilis metallo--lactamase tightly binds to two zinc ions at pH 7 (7), but the activity of the mono zinc form is unknown at present, and the same situation appears to prevail for the IMP-1 enzyme.

View this table: [in this window] [in a new window]   TABLE 5.   Metal/enzyme ratios and catalytic efficiencies of the metallo--lactamase at different pH valuesa

Conclusions. The spread of the IMP-1 metallo--lactamase in major nosocomial strains is one of the most powerful responses toward the anti-infective strategies widely used in several hospitals in Japan. In the study described in this report, a recombinant E. coli strain was used to produce large amount of IMP-1. The enzyme produced in E. coli and P. aeruginosa exhibited the same properties. The metal content of the protein was not significantly affected by the pH. Under all conditions tested except when citrate was used as the buffer, the metallo--lactamase contained two zinc ions. As expected, the enzyme was inactivated by metal chelating agents. These compounds did not act by scavenging the free metal, and therefore, the transient formation of a ternary enzyme-metal-chelator complex is proposed. Finally, at pH 7.5, the enzymatic activity was not influenced by the presence of increasing concentration of free zinc ions.

The di-zinc form of the enzyme exhibited a broad-spectrum activity profile. Only the monobactam compounds and temocillin seemed to escape the hydrolytic action of the metallo--lactamase. A comparison of the activities of the mono-zinc and di-zinc forms of IMP-1 is being performed. Furthermore, detailed structural and mechanistic studies of IMP-1 are in progress.

	ACKNOWLEDGMENTS

This work was supported in part by a grant from the European Union (grant ERBFMRCX-CT98-0232) as part of the Training and Mobility of Researchers Programme, by the Belgian Programme Poles d'Attraction Interuniversitaire initiated by the Belgian State, Prime Minister's Office, Services Fédéraux des Affaires Scientifiques, Techniques et Culturelles (PAI no. P4/03), and by a grant from MURST ex-40%, project Structural Biology. During his stay at the University of l'Aquila (Department STB), M.G. was supported by a grant from MURST and CNR.

M.G. thanks P.S. for patience and work in front of the Perkin-Elmer spectrophotometer. The ICPMS measurements were performed by the Laboratoire de la Santé et de l'Environnement, Institut Malvoz de la Province de Liège, Liège, Belgium.

	FOOTNOTES

^* Corresponding author. Mailing address: Laboratoire d'Enzymologie & Centre d'Ingénierie des Protéines, Institut de Chimie, B6 Sart Tilman, Université de Liège, B-4000 Liège, Belgium. Phone: 32-4-3663348. Fax: 32-4-3663364. E-mail: mgalleni{at}ulg.ac.be.

	REFERENCES

Top Abstract Introduction Materials and Methods References

1.	Ansorge, W., B. Sproat, J. Stegemann, C. Schwager, and M. Zenke. 1987. Automated DNA sequencing: ultrasensitive detection of fluorescent bands during electrophoresis. Nucleic Acids Res. 15:4593-4602[Abstract/Free Full Text].
2.	Bounaga, S., A. P. Laws, M. Galleni, and M. I. Page. 1998. Unusual pH dependence of the class B -lactamase catalysed hydrolysis of substrates and their inhibition by thiols. Biochem. J. 331:703-711.
3.	Bush, K., and G. Jacoby. 1995. A functional classification for -lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233[Medline].
4.	Carfi, A., S. Pares, E. Duée, M. Galleni, C. Duez, J. M. Frère, and O. Dideberg. 1995. The 3D structure of a zinc metallo--lactamase from Bacillus cereus reveals a new type of protein fold. EMBO J. 14:4914-4921[Medline].
5.	Carfi, A., E. Duée, R. P. Soto, M. Galleni, C. Duez, J. M. Frère, and O. Dideberg. 1998. X-ray structure of the Zn II -lactamase from Bacteroides fragilis in an orthorhombic crystal form. Acta Crystallogr. D54:47-57.
6.	Concha, N. O., B. A. Rasmussen, K. Bush, and O. Herzberg. 1996. Crystal structure of the wide-spectrum binuclear zinc -lactamase from Bacteroides fragilis. Structure 4:823-836[Medline].
7.	Crowder, M. W., T. R. Walsh, L. Banovic, M. Pettit, and J. Spencer. 1998. Overexpression, purification, and characterization of the cloned metallo--lactamase L1 from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 42:921-926[Abstract/Free Full Text].
8.	Crowder, M. W., Z. Wang, S. L. Franklin, E. P. Zovinka, and S. J. Benkovic. 1996. Characterisation of the metal binding sites of the -lactamase from Bacteroides fragilis. Biochemistry 35:12126-12132[Medline].
9.	Cuchural, G. J., Jr., M. H. Malamy, and F. P. Tally. 1986. -Lactamase-mediated imipenem resistance in Bacteroides fragilis. Antimicrob. Agents Chemother. 30:645-648[Abstract/Free Full Text].
10.	De Meester, F., B. Joris, G. Reckinger, C. Bellefroid-Bourguignon, J. M. Frère, and S. G. Waley. 1987. Automated analysis of enzyme inactivator phenomena. Biochem. Pharmacol. 36:2393-2403[Medline].
11.	Felici, A., and G. Amicosante. 1995. Kinetic analysis of extension of substrate specificity with Xanthomonas maltophilia, Aeromonas hydrophila, and Bacillus cereus metallo--lactamases. Antimicrob. Agents Chemother. 39:192-199[Abstract].
12.	Felici, A., G. Amicosante, A. Oratore, R. Strom, P. Ledent, B. Joris, L. Fanuel, and J. M. Frère. 1993. An overview of the kinetic parameters of class B -lactamase. Biochem. J. 291:151-155.
13.	Felici, A., M. Perilli, B. Segatore, N. Franceschini, D. Setacci, A. Oratore, S. Stefani, M. Galleni, and G. Amicosante. 1995. Interactions of biapenem with active-site serine and metallo--lactamases. Antimicrob. Agents Chemother. 39:1300-1305[Abstract].
14.	Frère, J. M. 1995. Beta-lactamases and bacterial resistance to antibiotics. Mol. Microbiol. 16:385-395[Medline].
15.	Galleni, M., N. Franceschini, B. Quinting, L. Fattorini, G. Orefici, A. Oratore, J. M. Frère, and G. Amicosante. 1994. Use of the chromosomal class A -lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory -lactam compounds. Antimicrob. Agents Chemother. 38:1608-1614[Abstract/Free Full Text].
16.	Hernandez Valladares, M., A. Felici, G. Weber, H. W. Adolph, M. Zeppezauer, G. M. Rossolini, G. Amicosante, J. M. Frère, and M. Galleni. 1997. Zn (II) dependence of the Aeromonas hydrophila AEO36 metallo--lactamase activity and stability. Biochemistry 36:11534-11541[Medline].
17.	Hussain, M., A. Carlino, M. J. Madonna, and O. Lampen. 1985. Cloning and sequencing of the metallothioprotein -lactamase II gene of Bacillus cereus 569H in Escherichia coli. J. Bacteriol. 164:223-229[Abstract/Free Full Text].
18.	Ito, H., Y. Arakawa, S. Ohsuka, R. Wachorotayankun, N. Kato, and M. Ohta. 1995. Plasmid-mediated dissemination of the metallo--lactamase gene blaIMP among clinically isolated strains of Serratia marcescens. Antimicrob. Agents Chemother. 39:824-829[Abstract].
19.	Laraki, N., M. Galleni, I. Thamm, M. L. Riccio, G. Amicosante, J.-M. Frere, and G. M. Rossolini. 1999. Structure of In101, a blaIMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes. Antimicrob. Agents Chemother. 43:818-829.
20.	Massida, O., G. M. Rossolini, and G. Satta. 1991. The Aeromonas hydrophila cphA gene: molecular heterogeneity among class B metallo--lactamases. J. Bacteriol. 173:4611-4617[Abstract/Free Full Text].
21.	Muramo, K., A. Takeda, Y. Nakamura, and K. Nakaya. 1995. Purification and characterization of metallo--lactamase from Serratia marcescens. Microbiol. Immunol. 39:27-33[Medline].
22.	Osano, E., Y. Arakawa, R. Wacharotayankun, M. Ohta, T. Horii, H. Ito, F. Yoshimura, and N. Kato. 1994. Molecular characterization of an enterobacterial metallo -lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38:71-78[Abstract/Free Full Text].
23.	Rasmussen, B. A., and K. Bush. 1997. Carbapenem-hydrolyzing beta-lactamases. Antimicrob. Agents Chemother. 41:223-232[Medline].
24.	Rossolini, G. M., N. Franceschini, M. L. Riccio, P. S. Mercuri, M. G. Perilli, M. Galleni, J. M. Frère, and G. Amicosante. 1998. Characterisation and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B -lactamase showing a broad substrate profile. Biochem. J. 332:145-152.
25.	Sanschagrin, F., J. Dufresne, and R. C. Levesque. 1998. Molecular heterogeneity of the L-1 metallo-beta-lactamase family from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 42:1245-1248[Abstract/Free Full Text].
26.	Sendo, H., Y. Arakawa, K. Nakeshima, H. Ito, S. Ichiyama, K. Shimakotu, N. Kato, and M. Ohta. 1986. Multifocal outbreak of metallo--lactamase producing Pseudomonas aeruginosa resistant to broad spectrum -lactam including carbapenems. Antimicrob. Agents Chemother. 40:349-353[Abstract].
27.	Waley, S. G. 1992. -Lactamase: mechanism of action, p. 198-228. In M. I. Page (ed.), The chemistry of -lactam. Blackie A. et P., London, United Kingdom.
28.	Walsh, T. R., L. Hall, S. J. Assinda, W. W. Nichols, S. J. Cartwright, A. P. MacGowan, and P. M. Bennett. 1994. Sequence and analysis of the L1 metallo--lactamase from Xanthomonas maltophilia. Biochem. Biophys. Acta 1218:199-201[Medline].
29.	Watanabe, M., S. Iyobe, M. Inoue, and S. Mitsuhashi. 1991. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 35:147-151[Abstract/Free Full Text].
30.	Yamaguchi, H., M. Nukaya, and T. Sawaï. 1994. Sequence of Klebsiella pneumoniae RDK4 metallo--lactamase. EMBO database accession no. D29636. EMBO, Heidelberg, Germany.
31.	Yang, Y., B. A. Rasmussen, and K. Bush. 1992. Biochemical characterization of an imipenem-hydrolyzing metallo--lactamase from Bacteroides fragilis TAL3636. Antimicrob. Agents Chemother. 36:1155-1157[Abstract/Free Full Text].

---

Antimicrobial Agents and Chemotherapy, April 1999, p. 902-906, Vol. 43, No. 4
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

This article has been cited by other articles:

• Brown, K. M., DePristo, M. A., Weinreich, D. M., Hartl, D. L. (2009). Temporal Constraints on the Incorporation of Regulatory Mutants in Evolutionary Pathways. Mol Biol Evol 26: 2455-2462 [Abstract] [Full Text]  
• Pellegrini, C., Mercuri, P. S., Celenza, G., Galleni, M., Segatore, B., Sacchetti, E., Volpe, R., Amicosante, G., Perilli, M. (2009). Identification of blaIMP-22 in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location. J Antimicrob Chemother 63: 901-908 [Abstract] [Full Text]  
• Juan, C., Beceiro, A., Gutierrez, O., Alberti, S., Garau, M., Perez, J. L., Bou, G., Oliver, A. (2008). Characterization of the New Metallo-{beta}-Lactamase VIM-13 and Its Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in Spain. Antimicrob. Agents Chemother. 52: 3589-3596 [Abstract] [Full Text]  
• Samuelsen, O., Castanheira, M., Walsh, T. R., Spencer, J. (2008). Kinetic Characterization of VIM-7, a Divergent Member of the VIM Metallo-{beta}-Lactamase Family. Antimicrob. Agents Chemother. 52: 2905-2908 [Abstract] [Full Text]  
• Stoczko, M., Frere, J.-M., Rossolini, G. M., Docquier, J.-D. (2008). Functional Diversity among Metallo-{beta}-Lactamases: Characterization of the CAR-1 Enzyme of Erwinia carotovora. Antimicrob. Agents Chemother. 52: 2473-2479 [Abstract] [Full Text]  
• Marchiaro, P., Tomatis, P. E., Mussi, M. A., Pasteran, F., Viale, A. M., Limansky, A. S., Vila, A. J. (2008). Biochemical Characterization of Metallo-{beta}-Lactamase VIM-11 from a Pseudomonas aeruginosa Clinical Strain. Antimicrob. Agents Chemother. 52: 2250-2252 [Abstract] [Full Text]  
• Livermore, D. M., Warner, M., Mushtaq, S. (2007). Evaluation of the chromogenic Cica-{beta}-Test for detecting extended-spectrum, AmpC and metallo-{beta}-lactamases. J Antimicrob Chemother 60: 1375-1379 [Abstract] [Full Text]  
• Horsfall, L. E., Garau, G., Lienard, B. M. R., Dideberg, O., Schofield, C. J., Frere, J. M., Galleni, M. (2007). Competitive Inhibitors of the CphA Metallo-{beta}-Lactamase from Aeromonas hydrophila. Antimicrob. Agents Chemother. 51: 2136-2142 [Abstract] [Full Text]  
• Koh, T. H., Sng, L.-H., Wang, G. C. Y., Hsu, L.-Y., Zhao, Y. (2007). IMP-4 and OXA {beta}-lactamases in Acinetobacter baumannii from Singapore. J Antimicrob Chemother 59: 627-632 [Abstract] [Full Text]  
• Stoczko, M., Frere, J.-M., Rossolini, G. M., Docquier, J.-D. (2006). Postgenomic Scan of Metallo-{beta}-Lactamase Homologues in Rhizobacteria: Identification and Characterization of BJP-1, a Subclass B3 Ortholog from Bradyrhizobium japonicum.. Antimicrob. Agents Chemother. 50: 1973-1981 [Abstract] [Full Text]  
• Pagani, L., Colinon, C., Migliavacca, R., Labonia, M., Docquier, J.-D., Nucleo, E., Spalla, M., Li Bergoli, M., Rossolini, G. M. (2005). Nosocomial Outbreak Caused by Multidrug-Resistant Pseudomonas aeruginosa Producing IMP-13 Metallo-{beta}-Lactamase. J. Clin. Microbiol. 43: 3824-3828 [Abstract] [Full Text]  
• Yamaguchi, Y., Kuroki, T., Yasuzawa, H., Higashi, T., Jin, W., Kawanami, A., Yamagata, Y., Arakawa, Y., Goto, M., Kurosaki, H. (2005). Probing the Role of Asp-120(81) of Metallo-{beta}-lactamase (IMP-1) by Site-directed Mutagenesis, Kinetic Studies, and X-ray Crystallography. J. Biol. Chem. 280: 20824-20832 [Abstract] [Full Text]  
• Giuliani, F., Docquier, J.-D., Riccio, M. L., Pagani, L., Rossolini, G. M. (2005). OXA-46, a New Class D {beta}-Lactamase of Narrow Substrate Specificity Encoded by a blaVIM-1-Containing Integron from a Pseudomonas aeruginosa Clinical Isolate. Antimicrob. Agents Chemother. 49: 1973-1980 [Abstract] [Full Text]  
• Walsh, T. R., Toleman, M. A., Poirel, L., Nordmann, P. (2005). Metallo-{beta}-Lactamases: the Quiet before the Storm?. Clin. Microbiol. Rev. 18: 306-325 [Abstract] [Full Text]  
• Riccio, M. L., Pallecchi, L., Docquier, J.-D., Cresti, S., Catania, M. R., Pagani, L., Lagatolla, C., Cornaglia, G., Fontana, R., Rossolini, G. M. (2005). Clonal Relatedness and Conserved Integron Structures in Epidemiologically Unrelated Pseudomonas aeruginosa Strains Producing the VIM-1 Metallo-{beta}-Lactamase from Different Italian Hospitals. Antimicrob. Agents Chemother. 49: 104-110 [Abstract] [Full Text]  
• Toleman, M. A., Biedenbach, D., Bennett, D. M. C., Jones, R. N., Walsh, T. R. (2005). Italian metallo-{beta}-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme. J Antimicrob Chemother 55: 61-70 [Abstract] [Full Text]  
• Castanheira, M., Toleman, M. A., Jones, R. N., Schmidt, F. J., Walsh, T. R. (2004). Molecular Characterization of a {beta}-Lactamase Gene, blaGIM-1, Encoding a New Subclass of Metallo-{beta}-Lactamase. Antimicrob. Agents Chemother. 48: 4654-4661 [Abstract] [Full Text]  
• Mendes, R. E., Toleman, M. A., Ribeiro, J., Sader, H. S., Jones, R. N., Walsh, T. R. (2004). Integron Carrying a Novel Metallo-{beta}-Lactamase Gene, blaIMP-16, and a Fused Form of Aminoglycoside-Resistant Gene aac(6')-30/aac(6')-Ib': Report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 48: 4693-4702 [Abstract] [Full Text]  
• Docquier, J.-D., Lopizzo, T., Liberatori, S., Prenna, M., Thaller, M. C., Frere, J.-M., Rossolini, G. M. (2004). Biochemical Characterization of the THIN-B Metallo-{beta}-Lactamase of Janthinobacterium lividum. Antimicrob. Agents Chemother. 48: 4778-4783 [Abstract] [Full Text]  
• Woodford, N., Tierno, P. M. Jr., Young, K., Tysall, L., Palepou, M.-F. I., Ward, E., Painter, R. E., Suber, D. F., Shungu, D., Silver, L. L., Inglima, K., Kornblum, J., Livermore, D. M. (2004). Outbreak of Klebsiella pneumoniae Producing a New Carbapenem- Hydrolyzing Class A {beta}-Lactamase, KPC-3, in a New York Medical Center. Antimicrob. Agents Chemother. 48: 4793-4799 [Abstract] [Full Text]  
• Nishio, H., Komatsu, M., Shibata, N., Shimakawa, K., Sueyoshi, N., Ura, T., Satoh, K., Toyokawa, M., Nakamura, T., Wada, Y., Orita, T., Kofuku, T., Yamasaki, K., Sakamoto, M., Kinoshita, S., Aihara, M., Arakawa, Y. (2004). Metallo-{beta}-Lactamase-Producing Gram-Negative Bacilli: Laboratory-Based Surveillance in Cooperation with 13 Clinical Laboratories in the Kinki Region of Japan. J. Clin. Microbiol. 42: 5256-5263 [Abstract] [Full Text]  
• Yomoda, S., Okubo, T., Takahashi, A., Murakami, M., Iyobe, S. (2003). Presence of Pseudomonas putida Strains Harboring Plasmids Bearing the Metallo-{beta}-Lactamase Gene blaIMP in a Hospital in Japan. J. Clin. Microbiol. 41: 4246-4251 [Abstract] [Full Text]  
• Damblon, C., Jensen, M., Ababou, A., Barsukov, I., Papamicael, C., Schofield, C. J., Olsen, L., Bauer, R., Roberts, G. C. K. (2003). The Inhibitor Thiomandelic Acid Binds to Both Metal Ions in Metallo-{beta}-lactamase and Induces Positive Cooperativity in Metal Binding. J. Biol. Chem. 278: 29240-29251 [Abstract] [Full Text]  
• Materon, I. C., Queenan, A. M., Koehler, T. M., Bush, K., Palzkill, T. (2003). Biochemical Characterization of {beta}-Lactamases Bla1 and Bla2 from Bacillus anthracis. Antimicrob. Agents Chemother. 47: 2040-2042 [Abstract] [Full Text]  
• Docquier, J.-D., Riccio, M. L., Mugnaioli, C., Luzzaro, F., Endimiani, A., Toniolo, A., Amicosante, G., Rossolini, G. M. (2003). IMP-12, a New Plasmid-Encoded Metallo-{beta}-Lactamase from a Pseudomonas putida Clinical Isolate. Antimicrob. Agents Chemother. 47: 1522-1528 [Abstract] [Full Text]  
• Oelschlaeger, P., Schmid, R. D., Pleiss, J. (2003). Insight into the mechanism of the IMP-1 metallo-{beta}-lactamase by molecular dynamics simulations. Protein Eng Des Sel 16: 341-350 [Abstract] [Full Text]  
• Murphy, T. A., Simm, A. M., Toleman, M. A., Jones, R. N., Walsh, T. R. (2003). Biochemical Characterization of the Acquired Metallo-{beta}-Lactamase SPM-1 from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 47: 582-587 [Abstract] [Full Text]  
• Docquier, J.-D., Lamotte-Brasseur, J., Galleni, M., Amicosante, G., Frere, J.-M., Rossolini, G. M. (2003). On functional and structural heterogeneity of VIM-type metallo-{beta}-lactamases. J Antimicrob Chemother 51: 257-266 [Abstract] [Full Text]  
• Toleman, M. A., Simm, A. M., Murphy, T. A., Gales, A. C., Biedenbach, D. J., Jones, R. N., Walsh, T. R. (2002). Molecular characterization of SPM-1, a novel metallo-{beta}-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother 50: 673-679 [Abstract] [Full Text]  
• Siemann, S., Evanoff, D. P., Marrone, L., Clarke, A. J., Viswanatha, T., Dmitrienko, G. I. (2002). N-Arylsulfonyl Hydrazones as Inhibitors of IMP-1 Metallo-{beta}-Lactamase. Antimicrob. Agents Chemother. 46: 2450-2457 [Abstract] [Full Text]  
• Docquier, J.-D., Pantanella, F., Giuliani, F., Thaller, M. C., Amicosante, G., Galleni, M., Frere, J.-M., Bush, K., Rossolini, G. M. (2002). CAU-1, a Subclass B3 Metallo-{beta}-Lactamase of Low Substrate Affinity Encoded by an Ortholog Present in the Caulobacter crescentus Chromosome. Antimicrob. Agents Chemother. 46: 1823-1830 [Abstract] [Full Text]  
• Payne, D. J., Hueso-Rodriguez, J. A., Boyd, H., Concha, N. O., Janson, C. A., Gilpin, M., Bateson, J. H., Cheever, C., Niconovich, N. L., Pearson, S., Rittenhouse, S., Tew, D., Diez, E., Perez, P., de la Fuente, J., Rees, M., Rivera-Sagredo, A. (2002). Identification of a Series of Tricyclic Natural Products as Potent Broad-Spectrum Inhibitors of Metallo-{beta}-Lactamases. Antimicrob. Agents Chemother. 46: 1880-1886 [Abstract] [Full Text]  
• Vessillier, S., Docquier, J.-D., Rival, S., Frere, J.-M., Galleni, M., Amicosante, G., Rossolini, G. M., Franceschini, N. (2002). Overproduction and Biochemical Characterization of the Chryseobacterium meningosepticum BlaB Metallo-{beta}-Lactamase. Antimicrob. Agents Chemother. 46: 1921-1927 [Abstract] [Full Text]  
• Iyobe, S., Kusadokoro, H., Takahashi, A., Yomoda, S., Okubo, T., Nakamura, A., O'Hara, K. (2002). Detection of a Variant Metallo-{beta}-Lactamase, IMP-10, from Two Unrelated Strains of Pseudomonas aeruginosa and an Alcaligenes xylosoxidans Strain. Antimicrob. Agents Chemother. 46: 2014-2016 [Abstract] [Full Text]  
• Franklin, K., Clarke, A. J. (2001). Overexpression and Characterization of the Chromosomal Aminoglycoside 2'-N-Acetyltransferase of Providencia stuartii. Antimicrob. Agents Chemother. 45: 2238-2244 [Abstract] [Full Text]  
• Bebrone, C., Moali, C., Mahy, F., Rival, S., Docquier, J. D., Rossolini, G. M., Fastrez, J., Pratt, R. F., Frère, J.-M., Galleni, M. (2001). CENTA as a Chromogenic Substrate for Studying {beta}-Lactamases. Antimicrob. Agents Chemother. 45: 1868-1871 [Abstract] [Full Text]  
• Yano, H., Kuga, A., Okamoto, R., Kitasato, H., Kobayashi, T., Inoue, M. (2001). Plasmid-Encoded Metallo-{beta}-Lactamase (IMP-6) Conferring Resistance to Carbapenems, Especially Meropenem. Antimicrob. Agents Chemother. 45: 1343-1348 [Abstract] [Full Text]  
• Mercuri, P. S., Bouillenne, F., Boschi, L., Lamotte-Brasseur, J., Amicosante, G., Devreese, B., van Beeumen, J., Frère, J.-M., Rossolini, G. M., Galleni, M. (2001). Biochemical Characterization of the FEZ-1 Metallo-{beta}-Lactamase of Legionella gormanii ATCC 33297T Produced in Escherichia coli. Antimicrob. Agents Chemother. 45: 1254-1262 [Abstract] [Full Text]  
• Rossolini, G. M., Condemi, M. A., Pantanella, F., Docquier, J.-D., Amicosante, G., Thaller, M. C. (2001). Metallo-{beta}-Lactamase Producers in Environmental Microbiota: New Molecular Class B Enzyme in Janthinobacterium lividum. Antimicrob. Agents Chemother. 45: 837-844 [Abstract] [Full Text]  
• Franceschini, N., Caravelli, B., Docquier, J.-D., Galleni, M., Frère, J.-M., Amicosante, G., Rossolini, G. M. (2000). Purification and Biochemical Characterization of the VIM-1 Metallo-beta -Lactamase. Antimicrob. Agents Chemother. 44: 3003-3007 [Abstract] [Full Text]  
• Haruta, S., Yamaguchi, H., Yamamoto, E. T., Eriguchi, Y., Nukaga, M., O'Hara, K., Sawai, T. (2000). Functional Analysis of the Active Site of a Metallo-beta -Lactamase Proliferating in Japan. Antimicrob. Agents Chemother. 44: 2304-2309 [Abstract] [Full Text]  
• Iyobe, S., Kusadokoro, H., Ozaki, J., Matsumura, N., Minami, S., Haruta, S., Sawai, T., O'Hara, K. (2000). Amino Acid Substitutions in a Variant of IMP-1 Metallo-beta -Lactamase. Antimicrob. Agents Chemother. 44: 2023-2027 [Abstract] [Full Text]  
• Bellais, S., Aubert, D., Naas, T., Nordmann, P. (2000). Molecular and Biochemical Heterogeneity of Class B Carbapenem-Hydrolyzing beta -Lactamases in Chryseobacterium meningosepticum. Antimicrob. Agents Chemother. 44: 1878-1886 [Abstract] [Full Text]  
• Riccio, M. L., Franceschini, N., Boschi, L., Caravelli, B., Cornaglia, G., Fontana, R., Amicosante, G., Rossolini, G. M. (2000). Characterization of the Metallo-beta -Lactamase Determinant of Acinetobacter baumannii AC-54/97 Reveals the Existence of blaIMP Allelic Variants Carried by Gene Cassettes of Different Phylogeny. Antimicrob. Agents Chemother. 44: 1229-1235 [Abstract] [Full Text]  
• Nagano, R., Adachi, Y., Hashizume, T., Morishima, H. (2000). In vitro antibacterial activity and mechanism of action of J-111,225, a novel 1{beta}-methylcarbapenem, against transferable IMP-1 metallo-{beta}-lactamase producers. J Antimicrob Chemother 45: 271-276 [Abstract] [Full Text]  
• Nagano, R., Adachi, Y., Imamura, H., Yamada, K., Hashizume, T., Morishima, H. (1999). Carbapenem Derivatives as Potential Inhibitors of Various beta -Lactamases, Including Class B Metallo-beta -Lactamases. Antimicrob. Agents Chemother. 43: 2497-2503 [Abstract] [Full Text]  
• Lauretti, L., Riccio, M. L., Mazzariol, A., Cornaglia, G., Amicosante, G., Fontana, R., Rossolini, G. M. (1999). Cloning and Characterization of blaVIM, a New Integron-Borne Metallo-beta -Lactamase Gene from a Pseudomonas aeruginosa Clinical Isolate. Antimicrob. Agents Chemother. 43: 1584-1590 [Abstract] [Full Text]  
• Toney, J. H., Hammond, G. G., Fitzgerald, P. M. D., Sharma, N., Balkovec, J. M., Rouen, G. P., Olson, S. H., Hammond, M. L., Greenlee, M. L., Gao, Y.-D. (2001). Succinic Acids as Potent Inhibitors of Plasmid-borne IMP-1 Metallo-beta -lactamase. J. Biol. Chem. 276: 31913-31918 [Abstract] [Full Text]  
• Mollard, C., Moali, C., Papamicael, C., Damblon, C., Vessilier, S., Amicosante, G., Schofield, C. J., Galleni, M., Frere, J.-M., Roberts, G. C. K. (2001). Thiomandelic Acid, a Broad Spectrum Inhibitor of Zinc beta -Lactamases. KINETIC AND SPECTROSCOPIC STUDIES. J. Biol. Chem. 276: 45015-45023 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Laraki, N. Articles by Galleni, M. Search for Related Content PubMed PubMed Citation Articles by Laraki, N. Articles by Galleni, M.